Thermo Fisher Scientific Inc.
NYSE-TMO
Basic
Market Cap
$226.93B
EV
$253.63B
Shares Out
381.72M
Revenue
$42.35B
Employees
122,000
Margins
Gross
40.61%
EBITDA
25.47%
Operating
17.63%
Pre-Tax
16.01%
Net
14.69%
FCF
18.8%
Returns (5Yr Avg)
ROA
8.2%
ROTA
29.03%
ROE
16.81%
ROCE
11.71%
ROIC
10.83%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$631.52
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$8,823M
Net Debt
$26.58B
Debt/Equity
0.74
EBIT/Interest
5.09
Growth (CAGR)
Rev 3Yr
3.45%
Rev 5Yr
11.23%
Rev 10Yr
11.02%
Dil EPS 3Yr
-9.27%
Dil EPS 5Yr
12.99%
Dil EPS 10Yr
15.41%
Rev Fwd 2Yr
3.54%
EBITDA Fwd 2Yr
4.27%
EPS Fwd 2Yr
5.98%
EPS LT Growth Est
9.32%
Dividends
Yield
—
Payout
9.14%
DPS
$1.48
DPS Growth 3Yr
15.52%
DPS Growth 5Yr
15.5%
DPS Growth 10Yr
9.45%
DPS Growth Fwd 2Yr
7.33%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)